1. Ding K#, Zhu Y#, Yan L#, Zhu L, Zhang TT, Zhang R, Li Q, Xie B, Ding L, Shang L, Wang Y, Xu P, Zhu T, Chen C, Zhu Y. Multiwalled Carbon Nanotubes-Reprogrammed Macrophages Facilitate Breast Cancer Metastasis via NBR2/TBX1 Axis. ACS Nano. 2024 Apr 30;18(17):11103-11119.
2. Dong L, Li L, Zhu L, Xu F, Zhang R, Li Q, Zhu Y, Zeng Z*, Ding K*. Multiomics analysis of homologous recombination deficiency across cancer types. Biomol Biomed. 2024 Jul 28.
3. Zhang R, Wang Z, Wang H, Li L, Dong L, Ding L, Li Q, Zhu L, Zhang T, Zhu Y*, Ding K*. CTHRC1 is associated with BRAF(V600E) mutation and correlates with prognosis, immune cell infiltration, and drug resistance in colon cancer, thyroid cancer, and melanoma. Biomol Biomed. 2024 Jul 23.
4. Li L, Bai L, Lin H, Dong L, Zhang R, Cheng X, Liu Z, Ouyang Y*, Ding K*. Multiomics analysis of tumor mutational burden across cancer types. Comput Struct Biotechnol J. 2021 Oct 12;19:5637-5646.
5. Zhu Y, Zhang R, Zhang Y, Cheng X, Li L, Wu Z*, Ding K*. NUDT21 Promotes Tumor Growth and Metastasis Through Modulating SGPP2 in Human Gastric Cancer. Front Oncol. 2021 Sep 30;11:670353.
6. Yan Y, Cheng X, Li L, Zhang R, Zhu Y, Wu Z*, Ding K*. A Novel Small Molecular Antibody, HER2-Nanobody, Inhibits Tumor Proliferation in HER2-Positive Breast Cancer Cells In Vitro and In Vivo. Front Oncol. 2021 May 12;11:669393.
7. Shi X#, Ding K#, Zhao Q, Li P, Kang Y, Tan S, Sun J. Suppression of CPSF6 Enhances Apoptosis Through Alternative Polyadenylation-Mediated Shortening of the VHL 3'UTR in Gastric Cancer Cells. Front Genet. 2021 Sep 14; 12:707644.
8. Xiang R, Han X, Ding K*, Wu Z*. CMIP promotes Herceptin resistance of HER2 positive gastric cancer cells. Pathol Res Pract. 2020 Feb; 216(2):152776.
9. Cheng X, Wang X, Wu Z, Tan S, Zhu T, Ding K*. CORO1C expression is associated with poor survival rates in gastric cancer and promotes metastasis in vitro. FEBS Open Bio. 2019 Jun; 9(6):1097-1108.
10. Ding K#, Tan S#, Huang X#, Wang X, Li X, Fan R, Zhu Y, Lobie PE, Wang W, Wu Z. GSE1 predicts poor survival outcome in gastric cancer patients by SLC7A5 enhancement of tumor growth and metastasis. J Biol Chem. 2018 Mar 16;293(11):3949-3964.
11. Ding K#, Wu Z#, Li X, Sheng Y, Wang X, Tan S. LMO4 mediates trastuzumab resistance in HER2 positive breast cancer cells. Am J Cancer Res. 2018 Apr 1;8(4):594-609.
12. Tan S#, Ding K#, Chong QY, Zhao J, Liu Y, Shao Y, Zhang Y, Yu Q, Xiong Z, Zhang W, Zhang M, Li G, Li X, Kong X, Ahmad A, Wu Z, Wu Q, Zhao X, Lobie PE, Zhu T. Post-tranional regulation of ERBB2 by miR26a/b and HuR confers resistance to tamoxifen in estrogen receptor-positive breast cancer cells. J Biol Chem. 2017 Aug 18;292(33):13551-13564.
13. Ding K#, Yuan Y, Chong QY, Yang Y, Li R, Li X, Kong X, Qian P, Xiong Z, Pandey V, Ma L, Wu Z, Lobie PE, Zhu T. Autocrine Prolactin Stimulates Endometrial Carcinoma Growth and Metastasis and Reduces Sensitivity to Chemotherapy. Endocrinology. 2017 Jun 1; 158(6):1595-1611.
14. Ding K#, Wu Z#, Wang N#, Wang X, Wang Y, Qian P, Meng G, Tan S. MiR-26a performs converse roles in proliferation and metastasis of different gastric cancer cells via regulating of PTEN expression. Pathol Res Pract. 2017 May; 213(5):467-475.
15. Lü M#, Ding K#, Zhang G, Yin M, Yao G, Tian H, Lian J, Liu L, Liang M, Zhu T, Sun F. MicroRNA-320a sensitizes tamoxifen-resistant breast cancer cells to tamoxifen by targeting ARPP-19 and ERRγ. Sci Rep. 2015 Mar 4; 5:8735.
16. Ding K#, Banerjee A#, Tan S, Zhao J, Zhuang Q, Li R, Qian P, Liu S, Wu ZS, Lobie PE, Zhu T. Artemin, a Member of the Glial Cell Line-derived Neurotrophic Factor Family of Ligands, Is HER2-regulated and Mediates Acquired Trastuzumab Resistance by Promoting Cancer Stem Cell-[like] Behavior in Mammary Carcinoma Cells. J Biol Chem. 2014 Jun 6; 289(23):16057-71.
17. Tan S#, Ding K#, Li R, Zhang W, Li G, Kong X, Qian P, Lobie PE, Zhu T. Identification of miR-26 as a key mediator of estrogen stimulated cell proliferation by targeting CHD1, GREB1 and KPNA2. Breast Cancer Res. 2014 Apr 15; 16(2):R40.
